Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Hancock named CEO
September 24, 2012
By: Tim Wright
Editor-in-Chief, Contract Pharma
Rick Hancock has been appointed chief executive officer of Althea Technologies. In addition, Chris Duffy has been named senior vice president of operations and E.J. Brandreth was named senior vice president of Quality and Regulatory. Mr. Hancock joined the company in 1998 and was previously president of Althea; he will retain the title of president in his new role. He has 30 years of biotechnology industry experience having held positions at Hybritech/Eli Lilly, Genetics Institute, and The Immune Response Corp. In his new role, Mr. Hancock will play a stronger role in the development of strategies to continue Althea’s growth efforts. Mr. Duffy joined the company 12 years ago and has been instrumental in the development of the company. He has more than 26 years of experience in the biotech industry managing biopharmaceutical development and sterile manufacturing operations. Under his leadership, Althea’s Fill Finish group has grown and transitioned from a clinical to a commercial operation. Mr. Duffy will employ his expertise in science and business in his new role. Mr. Brandreth has more than 20 years of experience in the biotechnology and pharmaceutical industries, having managed numerous agency inspections and led the process validation programs for five CBER/EMEA product launches. Additionally, Mr. Brandreth serves on Biocom’s FDA Committee, Interphex’s Advisory Board, and PDA’s Biotech Advisory Board as Chairman. Prior to joining the company, Mr. Brandreth was with Favrille and Biomarin where he supported a variety of clinical products and launched two commercial products. “I am very pleased to announce the promotions of Rick Hancock, Chris Duffy and E.J. Brandreth,” said Dr. Magda Marquet, co-founder and co-chairman of Althea Technologies. “These individuals truly embody the spirit of Althea by providing, through their leadership and dedication, unmatched service to the customer with uncompromised quality. I am confident each executive will play a crucial role in leading Althea to continued future growth.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !